Dr Joost van Herten joins Ethics Talk to discuss how comparing different conceptions of health can help us interrogate just exactly what a One Health approach to health offers and what it doesn't.
Dr Emily Cleveland Manchanda joins Ethics Talk to discuss her article, coauthored with Dr Karthik Sivashanker, Steffie Kinglake, Emily Laflamme, Dr Vikas Saini, and Dr Aletha Maybank: “Training to Build Antiracist, Equitable Health Care Systems.”
Dr Kimberly A. Singletary joins Ethics Talk to discuss her article, coauthored with Dr Marshall H. Chin: “What Should Antiracist Payment Reform Look Like?”
Bias toward allopathic medicine in the research funding and publication of study results makes it difficult for physicians and others to find accurate data about the efficacy of non-Western, nonallopathic treatments.
Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.
Michael Farias, MD, MS, MBA and Rahul H. Rathod, MD
A distinguishing feature of a SCAMP is its ability to capture knowledge-based diversions from a recommended pathway and to “learn” from such individualized patient management.